Summary. The affinity and the density of peripheral-type benzodiazepine binding sites (PBzS) in tissues from the genital organs of female rats were studied during the oestrous cycle. When comparing PBzS density on the day of oestrus to PBzS density on the day of pro-oestrus, a significant increase was observed in the ovary (1\m=.\9-fol d) oviduct (2\ m=. \ 4-f ol d) and uterus (1\m=.\7-fold), but not in the kidney. Serum oestradiol also increased to a maximum on the day of pro-oestrus. The ovarian and uterine PBzS density and serum concentrations of oestradiol and progesterone were measured every 8 h between the days of dioestrus and pro-oestrus. Ovarian and uterine PBzS density increased to a maximal value at 01:00 and 09:00 h, respectively, on the day of pro-oestrus. However, a significant increase in PBzS density occurred in the ovary (P < 0\m=.\02) and uterus (P < 0\m=.\001) at 09:00 h on the day of pro-oestrus as compared to 09:00 h on the day of dioestrus. These changes were associated with an increase in serum oestradiol and progesterone concentrations. The affinity of PBzS in all tissues examined remained unaltered during the oestrous cycle. This study demonstrates that changes associated with the oestrous cycle occur in the density of PBzS in various genital organs.
Introduction
Benzodiazepines are used clinically as anxiolytics, hypnotics, anticonvulsants and muscle relaxants. It has been suggested that the effect of benzodiazepines in the central nervous system is mediated by specific receptors which are coupled with the -aminobutyric acid (GABA) receptors (Tallman et al, 1978) .
Peripheral-type benzodiazepine binding sites (PBzS) have been identified in peripheral tissues such as lung, liver and kidney (Braestrup & Squires, 1977) , mast cells , platelets and uterus and oviduct (Fares et al, 1987) . PBzS differ from centraltype benzodiazepine receptors in their lack of coupling to GABA receptors and in their ligand specificity (Marangos et al, 1982) : Ro 5-4864 (a benzodiazepine) and PK 11195 (an isoquinoline carboxamide derivative) bind with high affinity to PBzS, but not to central-type benzodiazepine receptors. The reverse is true with regard to specific central-type ligands such as clonazepam.
PBzS are coupled to calcium channels (Mestre et al, 1985) . It has also been shown that a PBzS selective ligand, Ro 5-4864, blocks calcium channels in the heart, whereas PK 11195 reverses the 'Reprint requests to Dr M. Gavish. effect of Ro 5-4864 and even the effect of other known calcium ion channel blockers such as nitrendipine, nifedipine and verapamil (Mestre et al, 1985) .
PBzS have also been characterized in several endocrine organs such as the hypophysis Voigt et al, 1984) , adrenal, testis , term placenta (Fares & Gavish, 1985) and ovary (Fares et al, 1987) . Several studies indicate that PBzS density in the endocrine organs is affected by their trophic hormones: hypophysectomy reduced PBzS density in the testis and adrenal ; chronic treatment with oestrogen in adult male rats also reduced PBzS density in the testis (Gavish et al, 1986) ; and treatment with oestrogen or pregnant mares' serum gonadotrophin (PMSG) increased PBzS density in rat ovary, oviduct and uterus, but not in kidney (Fares et al, 1987) . It has been suggested that the effect of PMSG on the ovary, oviduct and uterus is mediated by ovarian oestrogen synthesis (Fares et al, 1987) .
The present study was therefore undertaken to examine the relationship between the cyclic changes in endogenous plasma oestradiol and progesterone concentrations during the rat oestrous cycle and PBzS density in the ovary, oviduct and uterus.
Materials and Methods
Ligands. [3H] (1951) .
Assays for serum oestradiol and progesterone concentrations. Oestradiol was measured by radioimmunoassay by using a kit from Isodan Diagnostic Laboratories, Jerusalem, Israel, with 125I-labelled oestradiol as the tracer hormone. The antibodies directed against oestradiol are very specific and have very low cross-reactivity with other steroids measured at 50% displacement compared to oestradiol. For the various tested androgens the cross-reactivity did not exceed 0005%; for oestriol and oestrone it was <0-5% and < 11-5%, respectively, and for progesterone it was <0-001%. Progesterone was measured by RIA using a kit from Diagnostic Products Corporation, Los Angeles, CA, U.S.A., with 125I-labelled progesterone as the tracer hormone. The antibodies directed against progesterone are very specific and have very low cross-reactivity with other steroids: androgens, not detectable; corticosterone, 0-4%; oestradiol, not detectable; and 20a-dihydroprogesterone, 20%. The sensitivities of the assays for oestradiol and progesterone were 5pg/ml and 005ng/ml, respectively.
Statistical analyses. days of the oestrous cycle. When comparing PBzS density on the day of oestrus to PBzS density on the day of pro-oestrus, a significant increase (P < 0-01) was observed in the ovary (1-9-fold), ovi¬ duct (2-4-fold) and uterus (1-7-fold), but not in the kidney (Table 1) (1-8 + 0-2) (1-6 + 0-3) (1-8 + 0-4) (1-6 + 0-3)
Values are mean ± s.e.m. for 7 rats.
*P < 0001 as compared to other days of the cycle of the same organ (one-way ANOVA).
PBzS density was measured over short time intervals (8 h) and compared to serum oestradiol and progesterone concentrations during days of dioestrus and pro-oestrus (Fig. 1 ). An increase in PBzS density in both ovary and uterus was associated with an increase in serum oestradiol and progesterone concentrations. The maximal increase in PBzS density in the ovary preceded by 8 h the maximal increase in PBzS density in the uterus.
Ovaries and uteri were grouped according to serum oestradiol and progesterone concentrations without reference to day of the oestrous cycle. Table 2 shows that the increase in PBzS density in the ovary and uterus was positively correlated with the increase in serum oestradiol concentration. A small increase in serum oestradiol concentration was sufficient for a significant increase in PBzS density in the ovary, whereas a significant increase in PBzS density in the uterus was noted only at larger increments of serum oestradiol concentration ( (Fig. 1) . Furthermore, when organs of all rats were pooled without reference to the day of the oestrous cycle, PBzS density in the ovary and uterus was positively correlated with the increasing concentration of serum oestradiol (Table 2) . Taken together, these findings suggest that the elevation in serum oestradiol induces the increases in PBzS density in the ovary, oviduct and uterus. It is possible that the slight increase in serum oestradiol concentration starting the night before the day of dioestrus (Smith et al, 1975) initiates the devel¬ opment of PBzS in the ovary and later on in the uterus. The decrease in PBzS density in the ovary, oviduct and uterus on the day of oestrus could result from the significant decrease in concentration of serum oestradiol. The significant increase in secretion of luteinizing hormone beginning on the afternoon of the day of pro-oestrus (Ayalon et al, 1972) could also account for the decrease in PBzS density.
In immature rats PBzS density measured between Days 23 and 27 after birth increased 1-3-and 1-9-fold in the oviduct and uterus, respectively, but remained unaltered in the ovary. This increase in PBzS density may be caused by the high serum oestradiol concentrations measured between Days 9 and 21 after birth (Döhler & Wuttke, 1975) . Subcutaneous insertion of a capsule containing diethylstilboestrol on Day 23 after birth for 4 days also caused a significant increase in PBzS density (P < 001) in the ovary, oviduct and uterus (Fares et al, 1987) . Similar treatment with progester¬ one did not alter the normal increase in PBzS density in the genital organs between Days 23 and 27 after birth (unpublished data), which suggests that progesterone is not involved in the increase in PBzS density. However, in adult rats the increase in PBzS density in the ovary and uterus was also associated with an increase in endogenous serum progesterone concentration. Nevertheless, when organs of all rats were pooled without reference to the day of the oestrous cycle, PBzS density in the ovary and uterus was not correlated with the increase in serum progesterone concentration. This could result from the pulsatile changes in serum progesterone concentration throughout the oes¬ trous cycle (Van der Schoot & de Greef, 1976; Kaneko et al, 1986) . Also, Fig. 1 shows fluctuations in serum progesterone concentrations during days of dioestrus and pro-oestrus. Thus, the possi¬ bility that progesterone is involved in the development of PBzS in the ovary and uterus cannot be excluded.
The decrease in PBzS density in the rat ovary, oviduct and uterus on the day of oestrus cannot be attributed to atretogenic activity in the ovary, since atretic follicles accumulate on the days of dioestrus and pro-oestrus, with a significant decline on the day of oestrus (Mandi & Zuckerman, 1950; Osman, 1985) , or in the uterus, since gap-junction formation is maximal (Garfield et al, 1978) and prostaglandin synthesis is maximal (Brown & Poyser, 1985) (Arguelles & Rosner, 1975) . Ro 5-4864 increases basal and human chorionic gonadotrophin-stimulated testosterone secretion of rat testis in vitro (Wilkinson et al, 1980; Ritta & Calandra, 1986) . Diazepam inhibits the secretion of rat prolactin in vivo and in vitro (Schettini et al, 1984) as well as the secretion of rat thyroid-stimulating hormone in vitro (Tapia-Arancibia et al, 1985) . Acute administration of low doses of benzodiazepines decreases basal concentrations of plasma corticosterone (Bruni et al, 1980) , whereas high doses cause the opposite effect (Marc & Morselli, 1969) . These effects of benzodiazepine-selective ligands are associated with high PBzS density in the target endocrine organ, such as testis, hypophysis and adrenal gland . Therefore, the presence of PBzS in the ovary, oviduct and uterus suggests a modulatory effect of benzodiazepines on these organs. In a preliminary study we have demonstrated that peripheral benzodiazepine-selective ligands modulate the endocrine activity of various organs in the genital axis. In female rats, diazepam and Ro 5-4864 decrease the oxytocin-dependent contractions of uterine strips (Y. Katz, F. Fares & M. Gavish, unpublished) . In humans, diazepam and Ro 5-4864 increase the secretion of progesterone and oestradiol in placental expiant culture (E. R. Barnea, F. Fares & M. Gavish, unpublished) .
The mode of benzodiazepinergic action on various organs is as yet unclear. It has been suggested that PBzS are located on the mitochondrial outer membrane (Anholt et al, 1986a, b) . It appears that PBzS correspond to the voltage-dependent anion channel, which admits molecules with molecular masses of < 1000 (De Pinto et al, 1985) . Porphyrins have been suggested to be the endogenous benzodiazepine ligand for mitochondrial PBzS, since porphyrins inhibit [3H] PK 11195 specific binding at nanomolar range (Verma et al, 1986) . Porphyrins are crucial for the activity of cytochrome enzymes, which are involved in the energy-consuming process (Harper et al, 1979) and steroidogenesis (Waterman & Simpson, 1985) . This evidence may shed some light on a possible mechanism by which benzodiazepines affect steroidogenesis and cell proliferation in response to hormones.
